Sufotidine
id:
sufotidine-233-7933940
title:
Sufotidine
text:
Sufotidine is a long-acting competitive H2 receptor antagonist which was under development as an antiulcerant by Glaxo. It was planned to be a follow-up compound to ranitidine (Zantac). When taken in doses of 600 mg twice daily it induced virtually 24-hour gastric anacidity thus closely resembling the antisecretory effect of the proton pump inhibitor omeprazole. Its development was terminated in 1989 from phase III clinical trials based on the appearance of carcinoid tumors in long-term toxicity
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Sufotidine
date created:
date modified:
2023-04-02T13:15:59Z
main entity:
{"identifier":"Q25323816","url":"https://www.wikidata.org/entity/Q25323816"}
image:
fields total:
13
integrity:
14